1. COVID-19 Vaccines Under Clinical Development

    Last Updated : 27 May, 2020 Candidate Platform Company/University Collaborator Primary Endpoint Primary Comp. Date Comments Vaccines Listed under WHO (as of 11th May, 2020) Ad5-nCoV (Recombinant Novel Coronavirus Vaccine - Adenovirus Type 5 Vector) Phase - II more

  2. COVID-19 Vaccines Under Pre-Clinical Development

    Last Updated : 27 May, 2020 Sr. No. Platform/Candidate Name Type of candidate vaccine Developer DNA Vaccines 1 DNA Vaccine DNA with electroporation Karolinska Institute / Cobra Biologics 2 DNA Vaccine DNA plasmid vaccine Osaka University/ AnGes/ Takara Bio 3 DNA more

  3. COVID-19 Impact on Global Oil Industry

    The oil industry is experiencing a dual supply and demand shock due to COVID-19-led lockdown measures across the world. In 2020, global oil demand is expected to decline by 9.3 mbd compared to last year, posing more

  1. Shift in Work Culture in Post-COVID–19 World

    The fear of COVID-19 has led to the need for social distancing and lockdowns across nations. Most corporates have introduced WFH policy to ensure business continuity. However, this policy can be sustainable only if it more

  2. COVID-19 Lockdown Plays Well for Gaming Industry

    Natural disasters, recessions, and other such devastating events tend to catalyze industry-wide trends and shift the power balance between sectors. COVID-19’s effect on various sectors, particularly gaming, will be in line with this notion. T more

  1. Smart Beta — Innovation, Meet Opportunity

    The tech bubble wiped out an estimated $30 trillion of wealth. The credit crisis that followed soon after further shook investor confidence in the markets. As a result, investors shifted from active management and hedge funds more

  2. Robo-Advisors — Innovation in a Time of ETFs

    Automated solutions can now provide investment advice at costs ranging between 0.15% - 0.50% as compared to the usual 1% fee that traditional investment advisors charge. What started off as experiments in providing low-cost investment advisory tools more